Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Modeling of the renal kinetics of the AT1 receptor specific PET radioligand [11C]KR31173.

Gulaldi NC, Xia J, Feng T, Hong K, Mathews WB, Ruben D, Kamel IR, Tsui BM, Szabo Z.

Biomed Res Int. 2013;2013:835859. doi: 10.1155/2013/835859.

2.

Image-derived and arterial blood sampled input functions for quantitative PET imaging of the angiotensin II subtype 1 receptor in the kidney.

Feng T, Tsui BM, Li X, Vranesic M, Lodge MA, Gulaldi NC, Szabo Z.

Med Phys. 2015 Nov;42(11):6736-44. doi: 10.1118/1.4934375.

3.

Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis.

Xia J, Seckin E, Xiang Y, Vranesic M, Mathews WB, Hong K, Bluemke DA, Lerman LO, Szabo Z.

Hypertension. 2008 Feb;51(2):466-73. doi: 10.1161/HYPERTENSIONAHA.107.102715.

4.

PET Imaging of the AT1 receptor with [11C]KR31173.

Zober TG, Mathews WB, Seckin E, Yoo SE, Hilton J, Xia J, Sandberg K, Ravert HT, Dannals RF, Szabo Z.

Nucl Med Biol. 2006 Jan;33(1):5-13.

5.

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.

Szabo Z, Scheffel U, Mathews WB, Ravert HT, Szabo K, Kraut M, Palmon S, Ricaurte GA, Dannals RF.

J Cereb Blood Flow Metab. 1999 Sep;19(9):967-81.

6.

A novel radioligand for imaging the AT1 angiotensin receptor with PET.

Mathews WB, Yoo SE, Lee SH, Scheffel U, Rauseo PA, Zober TG, Gocco G, Sandberg K, Ravert HT, Dannals RF, Szabo Z.

Nucl Med Biol. 2004 Jul;31(5):571-4.

PMID:
15219274
7.

Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.

Ismail B, Hadizad T, Antoun R, Lortie M, deKemp RA, Beanlands RS, DaSilva JN.

Nucl Med Biol. 2015 Nov;42(11):850-7. doi: 10.1016/j.nucmedbio.2015.06.012.

PMID:
26300209
8.

Analysis of [11C]methyl-candesartan kinetics in the rat kidney for the assessment of angiotensin II type 1 receptor density in vivo with PET.

Lortie M, DaSilva JN, Kirkpatrick SA, Hadizad T, Ismail BA, Beanlands RS, deKemp RA.

Nucl Med Biol. 2013 Feb;40(2):252-61. doi: 10.1016/j.nucmedbio.2012.10.013.

PMID:
23352346
9.

Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.

Higuchi T, Fukushima K, Xia J, Mathews WB, Lautamäki R, Bravo PE, Javadi MS, Dannals RF, Szabo Z, Bengel FM.

J Nucl Med. 2010 Dec;51(12):1956-61. doi: 10.2967/jnumed.110.079855.

10.

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.

Zhou Y, Resnick SM, Ye W, Fan H, Holt DP, Klunk WE, Mathis CA, Dannals R, Wong DF.

Neuroimage. 2007 Jun;36(2):298-312.

11.

In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET.

Owonikoko TK, Fabucci ME, Brown PR, Nisar N, Hilton J, Mathews WB, Ravert HT, Rauseo P, Sandberg K, Dannals RF, Szabo Z.

J Nucl Med. 2004 Jan;45(1):94-100.

12.

PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs.

Winterdahl M, Audrain H, Landau AM, Smith DF, Bonaventure P, Shoblock JR, Carruthers N, Swanson D, Bender D.

J Nucl Med. 2014 Apr;55(4):635-9. doi: 10.2967/jnumed.113.125351.

14.

Multi-graphical analysis of dynamic PET.

Zhou Y, Ye W, Brasić JR, Wong DF.

Neuroimage. 2010 Feb 15;49(4):2947-57. doi: 10.1016/j.neuroimage.2009.11.028.

15.

Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.

Hansen HD, Herth MM, Ettrup A, Andersen VL, Lehel S, Dyssegaard A, Kristensen JL, Knudsen GM.

J Nucl Med. 2014 Apr;55(4):640-6. doi: 10.2967/jnumed.113.128983.

16.

Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.

McCarron JA, Marchais-Oberwinkler S, Pike VW, Tarkiainen J, Halldin C, Sóvagó J, Gulyas B, Wikström HV, Farde L.

Mol Imaging Biol. 2005 May-Jun;7(3):209-19.

PMID:
15912425
17.

Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.

Mitkovski S, Villemagne VL, Novakovic KE, O'Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Gregoire MC, Bottlaender M, Dolle F, Rowe CC.

Nucl Med Biol. 2005 Aug;32(6):585-91.

PMID:
16026705
18.

Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors.

Fukushima K, Bravo PE, Higuchi T, Schuleri KH, Lin X, Abraham MR, Xia J, Mathews WB, Dannals RF, Lardo AC, Szabo Z, Bengel FM.

J Am Coll Cardiol. 2012 Dec 18;60(24):2527-34. doi: 10.1016/j.jacc.2012.09.023.

19.

In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.

Gallezot JD, Bottlaender M, Grégoire MC, Roumenov D, Deverre JR, Coulon C, Ottaviani M, Dollé F, Syrota A, Valette H.

J Nucl Med. 2005 Feb;46(2):240-7.

20.

Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.

Szabo Z, Kao PF, Burns HD, Gibson RE, Hamill TG, Ravert HT, Kim SE, Mathews WB, Musachio JL, Scheffel U, Dannals RF.

J Nucl Med. 1998 Jul;39(7):1209-13.

Items per page

Supplemental Content

Support Center